Mortality Transitions and Measurement: Historical Patterns and Global Variations

For most of human history, death was a constant, unpredictable companion. People lived short lives, children died in large numbers, and infectious diseases swept through populations with devastating regularity. But over the past two centuries, something remarkable happened – mortality patterns shifted dramatically. Understanding how and why this happened, and how we measure mortality today, is central to the field of population health and sustainability.

How mortality patterns have changed through history 🔗

Before the modern era, life expectancy hovered between just 20 and 30 years. Nearly half of all deaths occurred before a child reached the age of five. Famines, epidemics, and poor sanitation made survival a daily challenge. There were no antibiotics, no vaccines, and very limited understanding of what caused disease in the first place.

The first major turning point came with the establishment of agriculture and settled communities. Reliable food production brought improved nutrition and some degree of food security. Then, beginning in the 18th and 19th centuries, industrialisation and public health reforms – better sanitation, cleaner water supplies, and quarantine measures – started to push life expectancy upward. By the early 20th century, life expectancy in parts of Europe and North America had risen to roughly 40 years.

The second major leap came after the 1950s. Breakthroughs in medical and biological science – including widespread vaccination, the discovery and mass production of antibiotics, and advances in surgical techniques – dramatically reduced mortality from infectious diseases. Population growth rates surged during the 1950s, 60s, and 70s, as death rates fell faster than birth rates in many parts of the world. Today, global life expectancy stands at approximately 73.3 years, a figure that has rebounded after the temporary setback caused by the COVID-19 pandemic.

Omran’s epidemiological transition theory 🔗

One of the most influential frameworks for understanding historical mortality changes is Abdel R. Omran’s Epidemiological Transition Theory, first published in 1971. At its core, the theory argues that as societies modernise, the dominant causes of death shift from infectious and parasitic diseases to chronic and degenerative conditions.

The three stages of the transition 🔗

Omran described the transition in three distinct stages:

The age of pestilence and famine: This is the earliest stage, where life expectancy fluctuates between 20 and 40 years. Mortality is high and unpredictable, driven by epidemics, famines, and wars. Diseases like plague, smallpox, and cholera dominate as leading causes of death.

The age of receding pandemics: In this stage, epidemic outbreaks become less frequent and less severe. Improved nutrition, sanitation, and early public health interventions gradually bring mortality rates down. Life expectancy begins a sustained rise, reaching around 50 years or more.

The age of degenerative and human-made diseases: In this final stage, infectious diseases recede as major killers and are replaced by chronic, non-communicable conditions – cardiovascular disease, cancer, stroke, and diabetes. Life expectancy exceeds 50 years and continues to climb. This is the stage that most high-income countries currently occupy.

Later additions and criticisms 🔗

Omran himself later expanded the model. Some scholars proposed a “fourth stage” – the age of delayed degenerative diseases – to account for the renewed decline in heart disease mortality observed in many wealthy nations from the 1970s onward. Others suggested a fifth stage involving re-emerging infections and lifestyle-related diseases.

The theory has faced significant criticism over the decades. A major critique is that it assumes all countries follow a similar, linear progression, which does not match reality. Many low- and middle-income countries experience a “double burden” – infectious diseases remain prevalent among poorer populations even as wealthier groups already face rising rates of chronic illness. The theory also gives insufficient attention to social determinants of health and treats populations as homogeneous units, ignoring the enormous variation within countries by income, geography, and gender.

Despite these limitations, the epidemiological transition remains a valuable lens for understanding the broad sweep of mortality change – as long as it is treated as a framework for thinking rather than a rigid prediction.

Global differences in mortality patterns today 🔗

While life expectancy has risen globally, the gains have been far from uniform. According to United Nations data, the global average life expectancy in 2023 was about 70.8 years for males and 76.0 years for females. But the range is enormous – from around 57.7 years in Western Africa to 82.7 years in Western Europe.

In developed countries, average life expectancy sits around 79 years, with women typically living longer than men (approximately 82 years for women versus 77 for men). In less developed regions, the average drops to about 71 years. The least developed countries average around 65 years, with Sub-Saharan Africa recording some of the lowest figures globally, at approximately 62 years.

What drives these disparities? 🔗

Several factors account for these stark differences:

Healthcare investment: Countries that spend more on healthcare infrastructure, medical training, and public health programmes tend to have significantly lower mortality rates. Access to skilled birth attendants, emergency medical care, and essential medicines all play a role.

Socioeconomic conditions: Poverty, malnutrition, lack of education, and poor housing conditions all increase vulnerability to disease and death. In regions where large portions of the population lack clean water and basic sanitation, infectious diseases continue to claim lives that would be easily saved elsewhere.

Public health infrastructure: Effective disease surveillance, vaccination campaigns, and infection control measures make a measurable difference. The COVID-19 pandemic starkly illustrated this – global life expectancy dropped by 1.8 years between 2019 and 2021, with the Americas and South-East Asia regions hit hardest.

Gender gap: Women outlive men in virtually every country. This gap arises from a combination of biological factors – newborn boys are more vulnerable to certain diseases – and behavioural differences, including higher rates of smoking, alcohol use, and risk-taking among men.

Methods for measuring mortality 🔗

Accurate measurement of mortality is essential for public health planning, resource allocation, and assessing the effectiveness of health interventions. Demographers and epidemiologists use several key measures, each serving a different purpose.

Crude death rate (CDR) 🔗

The crude death rate is the most basic mortality measure. It is calculated as the total number of deaths in a population during a given time period, divided by the mid-period population, typically expressed per 1,000 or 100,000 people. For example, if a country with a population of 10 million records 80,000 deaths in a year, the crude death rate is 8 per 1,000.

The CDR is easy to calculate and widely available, but it has a significant limitation: it does not account for the age structure of the population. A country with a large elderly population may have a higher crude death rate than a younger country, even if actual health conditions are better.

Age-specific death rate (ASDR) 🔗

To overcome the limitation of the CDR, demographers calculate age-specific death rates. These measure mortality within specific age groups – for example, deaths among people aged 25-44, or among those over 65. The numerator is the number of deaths in that age group, and the denominator is the population within that same age group. These rates are typically calculated separately for males and females and reveal the characteristic J-shaped curve of mortality: relatively high in infancy, low through childhood and young adulthood, then rising steadily with age.

Infant mortality rate (IMR) 🔗

The infant mortality rate measures deaths among children under one year of age per 1,000 live births in a given year. It is one of the most widely used indicators for comparing health outcomes between nations because it reflects a wide range of underlying conditions – from maternal health and prenatal care to sanitation, nutrition, and access to medical services.

Countries with strong public health systems typically have infant mortality rates below 5 per 1,000 live births, while in some of the poorest nations, the rate can exceed 50 or even 70 per 1,000.

Child mortality rate (under-five mortality rate) 🔗

The child mortality rate broadens the lens to include all deaths among children under the age of five, per 1,000 live births. This measure captures not just neonatal risks but also threats from infectious diseases, malnutrition, and unsafe environments that affect toddlers and young children. It is a key indicator tracked under the United Nations Sustainable Development Goals. In 2023, the number of under-five deaths globally fell below 5 million for the first time in recent history – a sign of progress, though much work remains.

Standardised mortality rate (SMR) 🔗

When comparing mortality between two populations with different age structures, demographers use standardised mortality rates. This method applies the age-specific death rates of the population being studied to a standard reference population, producing a rate that removes the distorting effect of differences in age distribution. For instance, a country with a very young population might appear to have low mortality by crude measures alone – standardisation reveals whether its health outcomes are genuinely better or simply a reflection of demographics.

Life tables and mortality analysis 🔗

A life table is one of the most powerful tools in demographic analysis. It summarises the mortality experience of a population by showing, for each age, the probability of surviving to the next year, the number of people expected to be alive, and the remaining life expectancy.

How life tables work 🔗

Life tables typically start with a hypothetical cohort – say, 100,000 people born at the same time – and then apply observed age-specific mortality rates to track how many survive to each subsequent age. The result is a detailed picture of a population’s mortality pattern from birth to the oldest ages.

There are two main types. Period life tables use mortality rates from a single time period (for example, one calendar year) to construct a snapshot of current conditions. Cohort life tables track a real group of people born in the same year throughout their actual lifetimes, providing a retrospective view of mortality experience.

Practical applications 🔗

Life tables have wide-ranging practical uses. Insurance companies rely heavily on them to assess risk and set premiums – they need to know the probability that a policyholder of a given age and gender will survive for a specified number of years. Government agencies use life tables to plan pension systems, healthcare budgets, and social security programmes. Public health researchers use them to compare mortality across populations, track health improvements over time, and identify vulnerable groups.

Life tables also reveal important gender-based differences. In most countries, women have higher survival probabilities at every age, which is why life table data is typically presented separately for males and females. This disaggregation helps policymakers design targeted health interventions – for example, focusing on reducing male mortality from cardiovascular disease or accidents.

Beyond mortality alone, life tables can be extended to calculate healthy life expectancy – the number of years a person can expect to live in good health, free from serious disability. This measure provides a more nuanced picture than total life expectancy alone, since living longer is only beneficial if those additional years are spent in reasonable health.

Why mortality measurement matters for sustainability 🔗

Mortality is not just a demographic statistic – it is a reflection of a society’s overall wellbeing, equity, and sustainability. High infant mortality, large gender gaps in life expectancy, or persistent regional disparities all signal deeper structural problems: inadequate healthcare, poverty, environmental degradation, or social inequality.

Tracking mortality accurately helps governments and international organisations identify where interventions are most needed, measure the impact of health programmes, and hold themselves accountable to goals like the Sustainable Development Goals. Without reliable mortality data, it becomes nearly impossible to allocate resources effectively or to know whether progress is being made.

The epidemiological transition also has direct implications for sustainability planning. As countries shift from infectious to chronic disease burdens, they face new challenges – rising healthcare costs, ageing populations, and the need for long-term care systems. Planning for these transitions is essential for building health systems that are both effective and sustainable over the long term.

What do you think? How should countries that are still battling infectious diseases prepare for the inevitable rise of chronic conditions – can they tackle both simultaneously, or must one come before the other? And in your view, which single mortality measure tells us the most about a population’s overall health and wellbeing?

References

1. https://ourworldindata.org/life-expectancy
2. https://pmc.ncbi.nlm.nih.gov/articles/PMC2690264/
3. https://pmc.ncbi.nlm.nih.gov/articles/PMC2805833/
4. https://academic.oup.com/ije/article/51/4/1054/6525745
5. https://www.tandfonline.com/doi/full/10.3402/gha.v7.23574
6. https://worldpopulationreview.com/country-rankings/life-expectancy-by-country
7. https://www.who.int/news/item/24-05-2024-covid-19-eliminated-a-decade-of-progress-in-global-level-of-life-expectancy
8. https://archive.cdc.gov/www_cdc_gov/csels/dsepd/ss1978/lesson3/section3.html
9. https://www.who.int/data/gho/indicator-metadata-registry/imr-details/1
10. https://www.un.org/ht/node/221949
11. https://en.wikipedia.org/wiki/Life_table